Amount of interleukin 12 available at the tumor site is critical for tumor regression

Cancer Research

Volumn 56, Issue 11, 1996, Pages 2531-2534

  Colombo, Mario P ^a   Vagliani, Maddalena ^a   Spreafico, Fabio ^a   Parenza, Mariella ^a   Chiodoni, Claudia ^a   Melani, Cecilia ^a   Stoppacciaro, Antonella ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GANGLIOTETRAOSYLCERAMIDE; INTERLEUKIN 12; N METHYL N NITROSOURETHAN; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; COLON CARCINOMA; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC TRANSDUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE DEPLETION; LYMPHOCYTIC INFILTRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR LOCALIZATION; TUMOR REGRESSION;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; COLONIC NEOPLASMS; DNA PRIMERS; IMMUNOLOGIC MEMORY; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS;

EID: 0029898839     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Trinchieri, G. Interleukin-12, a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol., 13 251-276, 1995.
2. Brunda, M J , Luistro, L , Warrier, R. R., Wright, R B , Hubbard, B. R., Murphy, M., Wolf, S. F. and Gately, M. K. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J Exp Med , 178 1223-1230, 1993.
3. Nastala, C L., Edington, H. D , McKinney, T. G , Tahara, H., Nalesnik, M A., Brunda, M. J , Gately, M. K , Wolf, S F., Schreiber, R. D., Storkus, W. J., and Lotze, M T Recombmani IL-12 administration induces tumor regression in association with IFNγ production. J. Immunol., 153: 1697-1706, 1994.
4. Martinotti, A., Stoppacciaro, A., Vagliani, M., Melani, C., Spreafico, F., Wysocka, M., Parmiani, G., Trinchieri, G., and Colombo, M. P CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with IL-12 genes Eur. J Immunol , 25. 137-146, 1995.
5. Zou, J-P., Yamamoto, N., Fujii, T., Takenaka, H., Kobayashi, M., Herrmann, S. H., Wolf, S. F., Fujiwara, H., and Hamaoka, T. Systemic administration of rIL-12 induces complete tumor regression and protective immunity, response is correlated with a striking reversal of suppressed IFNγ production by anti-tumor T cells. Int. Immunol. 7. 1135-1145, 1995.
6. Tannenbaum, C. S., Wicker, N., Armstrong, D., Tubbs, R., Finke, J. Bukowski, R. M., and Hamilton, T. A. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J. Immunol., 156: 693-699, 1996.
7. Angiolillo, A. L , Sgadan, C., Taub, D. D., Liao, F., Farber, S. M., Maheshwari, S., Kleinman, H. K , Reaman, G. H., and Tosato, G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med., 182: 155-162, 1995.
8. Luster, A. D. Greenberg, S. M., and Leder, P The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med., 182: 219-231, 1995.
9. Brunda, M. J., Luistro, L., Hendrzak, J. A., Fountoulakis, M., Garotta, G., and Gately, M K. Role of IFNγ in mediating the antitumor efficacy of interleukin-12. J. Immunotherapy, 17: 71-77, 1995.
10. Vagliani, M , Rodolfo, M., Cavallo, F., Parenza, M., Melani, C., Parmiani, G., Forni, G., and Colombo, M. P. Interleukm 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells. Cancer Res., 56: 467-470, 1996.
11. Trembleau, S., Germann, T., Gately, M. K., and Adorini, L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today, 16: 383-386, 1995.
12. Tahara, H , Zeh, H J., III, Storkus, W. J., Pappo, I , Watkins, S C., Gubler, U., Wolf, S., Robbins, P. D., and Lotze, M. T. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res., 54: 182-189, 1994.
13. Tahara, H., Zirvogel, L., Storkus, W J , Zeth, III, H. G , McKinney, T. G., Schreiber, R. D , Gubler, U., Robbins, P D , and Lotze, M T. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 154: 6466-6474, 1995.
14. Corbett, T. H., Griswold, D. P., Jr., Roberts, B. J., Peekham, J. C., and Schabel, F. M., Jr Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assay, with a note on carcinogen structure. Cancer Res., 35: 2434-2437, 1975
15. Schoenhaut, D. S., Chua, A. O , Wolitzky, A. G , Quinn, P. M., Dwyer, C. M., McComas, W., Familetti, P. C., Gately, M K., and Gubler, U. Cloning and expression of murine IL-12. J Immunol., 148: 3433-3440, 1992.
16. Miller, D. A., and Rosmann, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980-986, 1989.
17. Elrot-Stein, O , Fuerst, T. R., and Moss, B. Cap-independent translation conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccina virus/bacteriophage T7 hybrid expression system. Proc. Natl. Acad. Sci. USA. 86: 6126-6130, 1989.
18. Markowitz, D., Goff, S. and Bank, A. A safe packaging line for gene transfer separating viral genes on two different plasmids. J. Virol., 62: 1120-1124, 1988.
19. Stoppacciaro, A. Melani, C., Parenza, M , Mastracchio, A , Bassi, C., Baroni, C., Parmiani, G , and Colombo, M. P Regression of an established tumor genetically modified 10 release G-CSF requires granulocyte-T cell cooperation and T cell-produced IFNγ J. Exp. Med., 178: 151-161, 1993.
20. Colombo, M P., Modesti, A., Parmiani, G., and Forni, G Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk Cancer Res., 52 4853-4857, 1992.
21. Noguchi, Y , Richards, E C , Chen, Y., and Old, L. J Influence of interleukin-12 on p53 peptide vaccination against established meth-A sarcoma. Proc Natl. Acad. Sci. USA, 92: 2219-2223, 1995.
22. + T lymphocytes in the primary and memory response to norummunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene transfection J. Immunol., 149. 3627-3635, 1992.
23. Car, B. D , Eng, V. M , Schnyder, B., LeHir, M , Shakhov, A. N., Woerly, G , Huang, S., Aguet, M , Anderson, T D., and Ryffel, B. Role of interferon-γ in interleukin 12-induced pathology in mice Am. J Pathol , 147: 1693-1707, 1995.